SCOPUS 정보 검색 플랫폼

Bulletin of the World Health Organization

Volumn 79, Issue 8, 2001, Pages 721-727

Private investment in AIDS vaccine development: Obstacles and solutions

(2) Batson, Amie a,b Ainsworth, Martha a

b Global Alliance for Vaccines and Immunization Financing Task Force (United States)

Author keywords

AIDS vaccines economics; Cost benefit analysis; Drug industry; Financial support; Investments; Motivation; Private sector (source: MeSH); Research

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIOTECHNOLOGY; INVESTMENT; PHARMACEUTICAL INDUSTRY; VACCINATION;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIOTECHNOLOGY; COST BENEFIT ANALYSIS; DRUG INDUSTRY; DRUG RESEARCH; HEALTH CARE FINANCING; HEALTH CARE ORGANIZATION; REVIEW;

AIDS VACCINES; BIOTECHNOLOGY; COST-BENEFIT ANALYSIS; DRUG EVALUATION; DRUG INDUSTRY; FINANCING, ORGANIZED; HUMANS; INVESTMENTS; PRIVATE SECTOR; RESEARCH;

EID: 0034889685 PISSN: 00429686 EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (12)

References (15)

1
- 0004212916
- New York, International AIDS Vaccine Initiative
- (2000) Accelerating global efforts in AIDS vaccine development: Scientific blueprint 2000

2
- 0004018557
- Washington, DC, World Bank, May
- (2000) Accelerating an AIDS vaccine for developing countries: Recommendations for the World Bank

3
- 0004323791
- Washington, DC, World Bank, (Background paper for World Bank AIDS Vaccine Task Force)
- (2000) HIV vaccine industry study
- Batson, A.¹ Whitehead, P.²

4
- 0004218983
- Washington, DC, World Bank, (Background paper for World Bank AIDS Vaccine Task Force)
- (2000) Mechanisms to accelerate development of an HIV/AIDS vaccine for developing countries
- Rosenhouse, S.¹

5
- 0004018557
- Washington, DC, World Bank, July
- (1999) Accelerating an AIDS vaccine for developing countries: Issues and options for the World Bank

6
- 0034631503
- Accelerating the development and future availability of HIV-1 vaccines: Why, when, where, and how?
- (2000) Lancet , vol.355 , pp. 2061-2066
- Esparza, J.¹ Bhamarapravati, N.²

7
- 0031959705
- Win-win interactions between the public and private sectors
- (1998) Nature Medicine , vol.4 , Issue.5 SUPPL. , pp. 487-491
- Batson, A.¹

8
- 0031229305
- Economic obstacles to the optimal utilization of an AIDS vaccine
- (1997) Journal of the International Association of Physicians for AIDS Care , vol.3 , Issue.9 , pp. 31-33
- Russell, P.K.¹

9
- 0003553381
- Cambridge, MA, National Bureau of Economic Research, (NBER working paper no. 7716)
- (2000) Creating markets for new vaccines. Part I: Rationale
- Kremer, M.¹

10
- 0034621014
- Vaccines and medicines for the world's poorest
- (2000) British Medical Journal , vol.320 , pp. 952-953
- Smith, R.¹

11
- 84862720115
- European Commission, (Internet communication, 3 April 2000)
- (2000) Making an AIDS vaccine available in the developing world

12
- 84862715468
- Washington, DC, White House, Office of the Press Secretary, (Press release, 28 January 2000; Internet communication, 2 July 2001)
- (2000) President Clinton unveils millennium initiative to promote delivery of existing vaccines in developing countries and accelerate development of new vaccines

13
- 84862722791
- Geneva, World Health Organization, (Press release WHO/61, 28 September 2000; Internet communication, 5 November 2000
- (2000) European Commission WHO and UNAIDS take a united stand against killer diseases

14
- 0004052659
- Kyushu-Okinawa Summit Meeting, (Internet communication, 2 April 2001)
- (2000) G8 communiqué Okinawa 2000

15
- 84862723605
- Global Alliance for Vaccines and Immunization. Draft policy paper on increasing access to immunization, 25 February (Internet communication, 5 April 2001)
- (2000) Immunize every child

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.